EDGAR·FLOW

Electra Therapeutics, Inc. — Form 4

Filed September 23, 2026 · analyzed by the Insider Agent
4 ▲ Likely positive significance 78/100
What the filing says
Director GORDON CARL L (ETRA) bought 6.9M shares (~$20.0M) on the open market (80% of holdings). Open-market insider purchase — historically a bullish signal.
Why this rating

Open-market insider purchase — historically a bullish signal.

Tradability signal
NO TRADE

No trade: positive news with only -2.4% moved so far — good news prices in within seconds and long-side continuation has shown no measured edge (this cell: -0.19% over 4 hrs, n=109). (Filing arrived outside market hours — evaluated at the next open with a live quote.)

Derived from this site's own measured outcomes + live price/liquidity at analysis time. An experiment, not investment advice.

Price action (we called it positive)
before filing · preread
$12.90 ▲ 1.84%
at our read · unknown
$12.67
+10 min · unknown
$12.26 ▼ 3.28%
+30 min · unknown
$12.45 ▼ 1.74%
+1 hr · unknown
$12.74 ▲ 0.55%
+4 hrs · unknown
$12.51 ▼ 1.30%

The stock had already moved -1.81% between hitting EDGAR and our read finishing — deltas above are measured from our read.

Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →

View original filing on SEC.gov ↗ ETRA · stock on Yahoo Finance ↗

See more from September 23, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.